AQP4 and Stroke: In conclusion, the ALPS index can reflect changes in AQP4-mediated glymphatic pathway function, suggesting a significant decline in the hyperacute phase and a notable recovery in the early chronic phase, which may have implications for stroke therapeutic strategies.